378 related articles for article (PubMed ID: 15824083)
1. Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma.
Rousseaux C; Lefebvre B; Dubuquoy L; Lefebvre P; Romano O; Auwerx J; Metzger D; Wahli W; Desvergne B; Naccari GC; Chavatte P; Farce A; Bulois P; Cortot A; Colombel JF; Desreumaux P
J Exp Med; 2005 Apr; 201(8):1205-15. PubMed ID: 15824083
[TBL] [Abstract][Full Text] [Related]
2. Reduction of peroxisome proliferation-activated receptor gamma expression by gamma-irradiation as a mechanism contributing to inflammatory response in rat colon: modulation by the 5-aminosalicylic acid agonist.
Linard C; Grémy O; Benderitter M
J Pharmacol Exp Ther; 2008 Mar; 324(3):911-20. PubMed ID: 18077625
[TBL] [Abstract][Full Text] [Related]
3. 5-Aminosalicylic Acid Ameliorates Colitis and Checks Dysbiotic Escherichia coli Expansion by Activating PPAR-γ Signaling in the Intestinal Epithelium.
Cevallos SA; Lee JY; Velazquez EM; Foegeding NJ; Shelton CD; Tiffany CR; Parry BH; Stull-Lane AR; Olsan EE; Savage HP; Nguyen H; Ghanaat SS; Byndloss AJ; Agu IO; Tsolis RM; Byndloss MX; Bäumler AJ
mBio; 2021 Jan; 12(1):. PubMed ID: 33468700
[TBL] [Abstract][Full Text] [Related]
4. Curcumin inhibits trinitrobenzene sulphonic acid-induced colitis in rats by activation of peroxisome proliferator-activated receptor gamma.
Zhang M; Deng C; Zheng J; Xia J; Sheng D
Int Immunopharmacol; 2006 Aug; 6(8):1233-42. PubMed ID: 16782535
[TBL] [Abstract][Full Text] [Related]
5. 5-aminosalicylic acid given in the remission stage of colitis suppresses colitis-associated cancer in a mouse colitis model.
Ikeda I; Tomimoto A; Wada K; Fujisawa T; Fujita K; Yonemitsu K; Nozaki Y; Endo H; Takahashi H; Yoneda M; Inamori M; Kubota K; Saito S; Nagashima Y; Nakagama H; Nakajima A
Clin Cancer Res; 2007 Nov; 13(21):6527-31. PubMed ID: 17975166
[TBL] [Abstract][Full Text] [Related]
6. Adjunct therapy of n-3 fatty acids to 5-ASA ameliorates inflammatory score and decreases NF-κB in rats with TNBS-induced colitis.
Mbodji K; Charpentier C; Guérin C; Querec C; Bole-Feysot C; Aziz M; Savoye G; Déchelotte P; Marion-Letellier R
J Nutr Biochem; 2013 Apr; 24(4):700-5. PubMed ID: 22841543
[TBL] [Abstract][Full Text] [Related]
7. Review article: mode of action and delivery of 5-aminosalicylic acid - new evidence.
Desreumaux P; Ghosh S
Aliment Pharmacol Ther; 2006 Sep; 24 Suppl 1():2-9. PubMed ID: 16939423
[TBL] [Abstract][Full Text] [Related]
8. Lactobacillus crispatus M247-derived H2O2 acts as a signal transducing molecule activating peroxisome proliferator activated receptor-gamma in the intestinal mucosa.
Voltan S; Martines D; Elli M; Brun P; Longo S; Porzionato A; Macchi V; D'Incà R; Scarpa M; Palù G; Sturniolo GC; Morelli L; Castagliuolo I
Gastroenterology; 2008 Oct; 135(4):1216-27. PubMed ID: 18722375
[TBL] [Abstract][Full Text] [Related]
9. Vanin-1 licenses inflammatory mediator production by gut epithelial cells and controls colitis by antagonizing peroxisome proliferator-activated receptor gamma activity.
Berruyer C; Pouyet L; Millet V; Martin FM; LeGoffic A; Canonici A; Garcia S; Bagnis C; Naquet P; Galland F
J Exp Med; 2006 Dec; 203(13):2817-27. PubMed ID: 17145956
[TBL] [Abstract][Full Text] [Related]
10. Genomic analysis of sulfasalazine effect in experimental colitis is consistent primarily with the modulation of NF-kappaB but not PPAR-gamma signaling.
Martínez-Augustin O; López-Posadas R; González R; Suárez MD; Zarzuelo A; Sánchez de Medina F
Pharmacogenet Genomics; 2009 May; 19(5):363-72. PubMed ID: 19365232
[TBL] [Abstract][Full Text] [Related]
11. Antioxidant properties of mesalamine in colitis inhibit phosphoinositide 3-kinase signaling in progenitor cells.
Managlia E; Katzman RB; Brown JB; Barrett TA
Inflamm Bowel Dis; 2013 Sep; 19(10):2051-60. PubMed ID: 23867870
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of 5-aminosalicyltaurine as a colon-specific prodrug of 5-aminosalicylic acid for treatment of experimental colitis.
Jung Y; Kim HH; Kim H; Kong H; Choi B; Yang Y; Kim Y
Eur J Pharm Sci; 2006 May; 28(1-2):26-33. PubMed ID: 16455235
[TBL] [Abstract][Full Text] [Related]
13. In vivo efficacy of microbiota-sensitive coatings for colon targeting: a promising tool for IBD therapy.
Karrout Y; Dubuquoy L; Piveteau C; Siepmann F; Moussa E; Wils D; Beghyn T; Neut C; Flament MP; Guerin-Deremaux L; Dubreuil L; Deprez B; Desreumaux P; Siepmann J
J Control Release; 2015 Jan; 197():121-30. PubMed ID: 25445696
[TBL] [Abstract][Full Text] [Related]
14. Effects of peroxisome proliferator-activated receptors-gamma ligands on dextran sodium sulphate-induced colitis in rats.
Celinski K; Dworzanski T; Korolczuk A; Piasecki R; Slomka M; Madro A; Fornal R
J Physiol Pharmacol; 2011 Jun; 62(3):347-56. PubMed ID: 21893696
[TBL] [Abstract][Full Text] [Related]
15. An anti-inflammatory mechanism of taurine conjugated 5-aminosalicylic acid against experimental colitis: taurine chloramine potentiates inhibitory effect of 5-aminosalicylic acid on IL-1beta-mediated NFkappaB activation.
Joo K; Lee Y; Choi D; Han J; Hong S; Kim YM; Jung Y
Eur J Pharmacol; 2009 Sep; 618(1-3):91-7. PubMed ID: 19616541
[TBL] [Abstract][Full Text] [Related]
16. 4-Hydroxydocosahexaenoic acid, a potent peroxisome proliferator-activated receptor gamma agonist alleviates the symptoms of DSS-induced colitis.
Yamamoto K; Ninomiya Y; Iseki M; Nakachi Y; Kanesaki-Yatsuka Y; Yamanoue Y; Itoh T; Nishii Y; Petrovsky N; Okazaki Y
Biochem Biophys Res Commun; 2008 Mar; 367(3):566-72. PubMed ID: 18191038
[TBL] [Abstract][Full Text] [Related]
17. Enhanced activity of a hydrogen sulphide-releasing derivative of mesalamine (ATB-429) in a mouse model of colitis.
Fiorucci S; Orlandi S; Mencarelli A; Caliendo G; Santagada V; Distrutti E; Santucci L; Cirino G; Wallace JL
Br J Pharmacol; 2007 Apr; 150(8):996-1002. PubMed ID: 17339831
[TBL] [Abstract][Full Text] [Related]
18. PPARgamma as a new therapeutic target in inflammatory bowel diseases.
Dubuquoy L; Rousseaux C; Thuru X; Peyrin-Biroulet L; Romano O; Chavatte P; Chamaillard M; Desreumaux P
Gut; 2006 Sep; 55(9):1341-9. PubMed ID: 16905700
[TBL] [Abstract][Full Text] [Related]
19. A molecular mechanism for the anti-inflammatory effect of taurine-conjugated 5-aminosalicylic acid in inflamed colon.
Kim H; Jeon H; Kong H; Yang Y; Choi B; Kim YM; Neckers L; Jung Y
Mol Pharmacol; 2006 Apr; 69(4):1405-12. PubMed ID: 16407467
[TBL] [Abstract][Full Text] [Related]
20. Effect of dexamethasone on peroxisome proliferator activated receptor-gamma mRNA expression in 3T3-L1 adipocytes with the human recombinant adiponectin.
She QM; Zhao J; Wang XL; Zhou CM; Shi XZ
Chin Med J (Engl); 2007 Jan; 120(2):155-8. PubMed ID: 17335662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
